AlphaYou
Overview
Smart money at a glance
Filings to Oct 6, 2026Net selling: insiders sold $3K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$3K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- 52-wk high
- $2.14
- 52-wk low
- $0.47
- Mkt cap
- $4.4M
- Fwd P/E
- 1428.6x
- Beta
- 4.95
- P/S
- 10.2x
- P/B
- 0.8x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -1709.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about RDHL filings
Are insiders buying or selling Redhill Biopharma Ltd (RDHL) stock?
Net selling: insiders sold $3K and bought $0 of RDHL stock on the open market in the 90 days to Oct 6, 2026, according to SEC Form 4 filings. The largest was Raday, Gilead (Chief Operating Officer), who sold $3K. The latest filing was on Oct 6, 2026.
Which members of Congress have traded RDHL recently?
None. No member of Congress disclosed a RDHL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this RDHL smart-money data?
This summary uses filings available on Oct 6, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
1 fund holds a position and insiders have been net selling.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in RDHL right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
What the street expects next
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- P/E
- 0.00
- Forward P/E
- 1428.57
- Market cap
- $4M
Valuation
- P/S10.21
- P/B0.78
Quality
- Operating margin0.0%
- ROE-1709.0%
- ROA-22.4%
Growth
- Beta4.95
Technicals
Price structure
Market data unavailable.